Chiu, Yen-LingYen-LingChiuShu, Kai-HsiangKai-HsiangShuFENG-JUNG YANGChou, Tzu-YingTzu-YingChouPING-MIN CHENLay, Fang-YunFang-YunLaySZU-YU PANLin, Cheng-JuiCheng-JuiLinLitjens, Nicolle H RNicolle H RLitjensBetjes, Michiel G HMichiel G HBetjesBermudez, SelmaSelmaBermudezKao, Kung-ChiKung-ChiKaoJEAN-SAN CHIAWang, GeorgeGeorgeWangPeng, Yu-SenYu-SenPengChuang, Yi-FangYi-FangChuang2019-07-242019-07-2420181742-4933https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056376717&doi=10.1186%2fs12979-018-0131-x&partnerID=40&md5=58191d9f23a43ccc61b54a8967c6fd20https://scholars.lib.ntu.edu.tw/handle/123456789/415241Patients with end-stage renal disease (ESRD) exhibit a premature aging phenotype of the immune system. Nevertheless, the etiology and impact of these changes in ESRD patients remain unknown.enAging; CVD; ESRD; Immunosenescence; Inflammation[SDGs]SDG3indican; para cresyl sulfate; unclassified drug; uremic toxin; adaptive immunity; adult; aging; Article; cardiovascular disease; CD4 lymphocyte count; CD4+ T lymphocyte; CD8 lymphocyte count; CD8+ T lymphocyte; cell level; cohort analysis; controlled study; coronary artery disease; cross-sectional study; diabetes mellitus; disease association; end stage renal disease; female; hemodialysis; hemodialysis patient; human; human cell; immunophenotyping; immunosenescence; inflammation; innate immunity; longitudinal study; lymphocyte differentiation; major clinical study; male; middle aged; monocyte; monocyte count; observational study; prediction; prevalence; priority journal; T lymphocytejournal article10.1186/s12979-018-0131-x304557212-s2.0-85056376717WOS:000449866100001https://api.elsevier.com/content/abstract/scopus_id/85056376717